Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Influenza

  Free Subscription


23.01.2017

1 Antiviral Res
1 Epidemiol Infect
1 J Gen Virol
1 J Virol
2 Lancet Respir Med
2 MMWR Morb Mortal Wkly Rep
2 PLoS One
3 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antiviral Res

  1. HU Y, Musharrafieh R, Ma C, Zhang J, et al
    An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Antiviral Res. 2017 Jan 10. pii: S0166-3542(16)30522.
    PubMed     Text format     Abstract available


    Epidemiol Infect

  2. ZHAO H, Harris RJ, Ellis J, Donati M, et al
    Epidemiology of parainfluenza infection in England and Wales, 1998-2013: any evidence of change?
    Epidemiol Infect. 2017 Jan 18:1-11. doi: 10.1017/S095026881600323.
    PubMed     Text format     Abstract available


    J Gen Virol

  3. YANG J, Lee J, Ma J, Lang Y, et al
    Pathogenicity of modified bat influenza virus with different M genes and its reassortment potential with swine influenza A virus.
    J Gen Virol. 2017 Jan 18. doi: 10.1099/jgv.0.000715.
    PubMed     Text format     Abstract available


    J Virol

  4. TANG X, Yang Y, Xia X, Zhang C, et al
    Recombinant adenoviruses displaying matrix 2 ectodomain epitopes (M2e) on their fiber proteins as universal influenza vaccines.
    J Virol. 2017 Jan 18. pii: JVI.02462-16. doi: 10.1128/JVI.02462.
    PubMed     Text format     Abstract available


    Lancet Respir Med

  5. MARTY FM, Vidal-Puigserver J, Clark C, Gupta SK, et al
    Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial.
    Lancet Respir Med. 2017 Jan 13. pii: S2213-2600(16)30435.
    PubMed     Text format     Abstract available

  6. RELLO J
    Theranostics in severe influenza.
    Lancet Respir Med. 2017 Jan 13. pii: S2213-2600(17)30005.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep


  7. Notice to Readers: Final MMWR Issue Including Table III Data.
    MMWR Morb Mortal Wkly Rep. 2017;65:1496.
    PubMed     Text format     Abstract available

  8. BARBER A, Muscoplat MH, Fedorowicz A
    Coverage with Tetanus, Diphtheria, and Acellular Pertussis Vaccine and Influenza Vaccine Among Pregnant Women - Minnesota, March 2013-December 2014.
    MMWR Morb Mortal Wkly Rep. 2017;66:56-59.
    PubMed     Text format     Abstract available


    PLoS One

  9. PRAPHASIRI P, Ditsungneon D, Greenbaum A, Dawood FS, et al
    Do Thai Physicians Recommend Seasonal Influenza Vaccines to Pregnant Women? A Cross-Sectional Survey of Physicians' Perspectives and Practices in Thailand.
    PLoS One. 2017;12:e0169221.
    PubMed     Text format     Abstract available

  10. HOWARD LM, Hoek KL, Goll JB, Samir P, et al
    Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial.
    PLoS One. 2017;12:e0167488.
    PubMed     Text format     Abstract available


    Vaccine

  11. YANG L, Nan H, Liang J, Chan YH, et al
    Influenza vaccination in older people with diabetes and their household contacts.
    Vaccine. 2017 Jan 13. pii: S0264-410X(17)30007.
    PubMed     Text format     Abstract available

  12. TREANOR JJ, Chu L, Essink B, Muse D, et al
    Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial.
    Vaccine. 2017 Jan 11. pii: S0264-410X(16)31286.
    PubMed     Text format     Abstract available

  13. ZHANG W, Hirve S, Kieny MP
    Seasonal vaccines - Critical path to pandemic influenza response.
    Vaccine. 2017 Jan 10. pii: S0264-410X(16)31289.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: